ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Research Topic : Notch Signalling Pathway
Australian State/Territory : VIC
Clear All
Filter by Field of Research
Basic Pharmacology (5)
Signal Transduction (5)
Cancer Therapy (excl. Chemotherapy and Radiation Therapy) (3)
Biochemistry and Cell Biology not elsewhere classified (2)
Cell Development, Proliferation and Death (2)
Cell Metabolism (2)
Central Nervous System (2)
Molecular Targets (2)
Cancer Cell Biology (1)
Cellular Nervous System (1)
Endocrinology (1)
Gastroenterology and Hepatology (1)
Innate Immunity (1)
Medical Bacteriology (1)
Medical Virology (1)
Medical biochemistry - carbohydrates (1)
Nutritional science (1)
Oncology and Carcinogenesis (1)
Orthopaedics (1)
Pharmacology and Pharmaceutical Sciences not elsewhere classified (1)
Protein Targeting And Signal Transduction (1)
Reproduction (1)
Sport and exercise nutrition (1)
Structural Biology (incl. Macromolecular Modelling) (1)
Filter by Socio-Economic Objective
Search did not return any results.
Filter by Funding Provider
National Health and Medical Research Council (43)
Filter by Status
Closed (41)
Filter by Scheme
Project Grants (24)
NHMRC Project Grants (9)
Early Career Fellowships (2)
Ideas Grants (2)
Research Fellowships (2)
Career Development Fellowships (1)
Development Grants (1)
Postgraduate Scholarships (1)
Program Grants (1)
Filter by Country
Australia (41)
Filter by Australian State/Territory
VIC (41)
NSW (5)
ACT (3)
QLD (2)
SA (1)
WA (1)
  • Researchers (0)
  • Funded Activities (43)
  • Organisations (0)
  • Funded Activity

    Humanisation And Pre-clinical Validation Of A Therapeutic Anti-cancer Antibody

    Funder
    National Health and Medical Research Council
    Funding Amount
    $699,136.00
    Summary
    This grant will develop a novel antibody against a protease expressed on cancer cells. Preclinical studies, and antibody humanisation, will be performed. This project will also provide vital information on optimal therapeutic approaches with the antibody that can be ultimately taken into human trials.
    More information
    Funded Activity

    ADAM Metalloprotease Inhibition For Treatment Of Colorectal Cancer

    Funder
    National Health and Medical Research Council
    Funding Amount
    $770,925.00
    Summary
    Colorectal cancer (CRC) causes over 4000 deaths/year, typically from developing drug resistance and spreading to other organs (metastasis). These processes involve tumour cells called cancer stem cells (CSCs), which rely on specific cell surface proteins for survival and function. We are developing antibodies against one of these type of proteins, to test in mouse models of CRC. These already show promise in targeting CSCs and inhibiting drug-resistance and metastasis in mice.
    More information
    Funded Activity

    Controlling Neuroinflammation In Alzheimer's Disease

    Funder
    National Health and Medical Research Council
    Summary
    Alzheimer’s disease (AD) is the most common neurodegenerative disorder worldwide, with 269,000 Australians currently diagnosed with AD and is expected to soar to about 981,000 by 2050. AD accounts for greater than 60% of all cases of dementia. This grant investigates the role that neuroinflammation plays in the progression and exacerbation of AD and will identify new therapeutic strategies to combat this insidious disease.
    More information
    Funded Activity

    The Role Of Cellular Microdomains In G-protein Coupled Receptor Signalling.

    Funder
    National Health and Medical Research Council
    Funding Amount
    $385,297.00
    Summary
    Molecules communicate with cells by attaching to proteins called receptors on the outside of cells, and triggering a series of events inside the cell. These events initially include the assembly of multiple proteins at the cell surface. This project will examine the formation of receptors and other proteins into these ‘communication complexes’. This will provide novel targets for more selective drug development.
    More information
    Funded Activity

    Controlling Neuroinflammation In Alzheimers Disease

    Funder
    National Health and Medical Research Council
    Funding Amount
    $639,577.00
    Summary
    Alzheimer’s disease (AD) is the most common neurodegenerative disorder worldwide, with 269,000 Australians currently diagnosed with AD and is expected to soar to about 981,000 by 2050. AD accounts for greater than 60% of all cases of dementia. This grant investigates the role that neuroinflammation plays in the progression and exacerbation of AD and will identify new therapeutic strategies to combat this insidious disease.
    More information
    Funded Activity

    Regulation Of Lipid Metabolism By AMP Activated Protein Kinase

    Funder
    National Health and Medical Research Council
    Funding Amount
    $478,776.00
    Summary
    Western communities are experiencing an epidemic of overweight and obesity that is contributing to diabetes, heart disease, and premature death. This project is investigating an enzyme, called AMP-activated protein kinase, that plays a pivotal role in controlling how our bodies control energy metabolism in response to exercise. Improved understanding about how this enzyme regulates the body's storage and breakdown of fat and responsiveness to insulin will enable the development of new medicines .... Western communities are experiencing an epidemic of overweight and obesity that is contributing to diabetes, heart disease, and premature death. This project is investigating an enzyme, called AMP-activated protein kinase, that plays a pivotal role in controlling how our bodies control energy metabolism in response to exercise. Improved understanding about how this enzyme regulates the body's storage and breakdown of fat and responsiveness to insulin will enable the development of new medicines for the treatment of obesity and the prevention of diabetes.
    Read more Read less
    More information
    Funded Activity

    MLKL-regulated Necroptosis Pathways In Disease

    Funder
    National Health and Medical Research Council
    Funding Amount
    $610,683.00
    Summary
    Only recently has it emerged that our cells have a built-in backup mechanism that instructs cells to die in extreme cases, such as when viruses have hijacked a cell. A misfiring backup mechanism is thought to underlie a number of human diseases, including inflammatory disease. Our investigation will establish a starting point for the development of novel anti-inflammatory drugs.
    More information
    Funded Activity

    Conologues: Ultra-fast-acting Therapeutic Insulins Based On Cone Snail Venom Insulin Principles

    Funder
    National Health and Medical Research Council
    Funding Amount
    $1,082,866.00
    Summary
    The increasing prevalence of Type 1 and Type 2 diabetes demands better treatments. Our Project is based on a fascinating discovery by our international team of CIs of a new type of insulin within marine organisms that could form the basis of a novel diabetes therapeutic. Within our Project we will exploit this discovery to develop a new class of ultra-rapid-acting therapeutic insulins.
    More information
    Funded Activity

    Regulation Of Protein Kinases And Their Substrates

    Funder
    National Health and Medical Research Council
    Funding Amount
    $582,000.00
    Summary
    Western communities are experiencing an obesity epidemic with up to half the population being overweight. Sedentary life styles and high caloric intake are the cause and will contribute to the development of age onset diseases including obesity, diabetes, cardiovascular disease, stroke and neurodegeneration. This project is investigating an enzyme that plays a pivotal role in controlling the body s response to exercise and diet. The key enzyme involved in this process is called the AMP-activated .... Western communities are experiencing an obesity epidemic with up to half the population being overweight. Sedentary life styles and high caloric intake are the cause and will contribute to the development of age onset diseases including obesity, diabetes, cardiovascular disease, stroke and neurodegeneration. This project is investigating an enzyme that plays a pivotal role in controlling the body s response to exercise and diet. The key enzyme involved in this process is called the AMP-activated protein kinase. This work will increase our understanding of the health benefits of diet and exercise. This new knowledge will play a vital role in developing new therapies for promoting exercise and mitigating the effects of diet that will improve health during the ageing process.
    Read more Read less
    More information
    Funded Activity

    Signalling Networks As Targets For Antibody Therapy In Glioma.

    Funder
    National Health and Medical Research Council
    Funding Amount
    $526,683.00
    Summary
    Antibodies are a major component of the bodies immune system that bind (i.e. stick) to foreign substances such as viruses. Once bound, these antibodies can activate other parts of the immune system, which help destroy the foreign substance. Analogous to the situation above, a number of institutions are testing antibodies that bind to cancer cells, in order to determine if they are able to destroy these cells. It is also possible to generate antibodies that bind to receptors on the surface of can .... Antibodies are a major component of the bodies immune system that bind (i.e. stick) to foreign substances such as viruses. Once bound, these antibodies can activate other parts of the immune system, which help destroy the foreign substance. Analogous to the situation above, a number of institutions are testing antibodies that bind to cancer cells, in order to determine if they are able to destroy these cells. It is also possible to generate antibodies that bind to receptors on the surface of cancer cells and block their function. If you target a receptor critical to the growth or survival of a cancer cell in this way, then swtiching-off this signal may inhibit tumor growth. In this proposal we plan to test a panel antibodies that recognize receptors important to the growth of brain cancer. Two of these antibodies have been generated and the other two will be made as part of this proposal. A key aspect of this proposal will be testing these antibodies in combination to determine how many receptors need to be targeted in order to get complete tumor regressions in animal models. Overall this work will help us identify new therapeutic strategies for the treatment of brain cancer. Finally, we will also analyze the way different receptors interact together in brain cancer cells.
    Read more Read less
    More information

    Showing 1-10 of 43 Funded Activites

    • 1
    • 2
    • 3
    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback